Schedule 13G ownership disclosure
MOLECULIN BIOTECH INC
Security class unavailable · CUSIP: 60855D101
Event date: 2017-02-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 800,093
- Percent of class
- 5.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000070
- Form type
- SC 13G
- Filer
- Moleculin Biotech, Inc.
- CIK
- CIK 1659617
- Filed
- Feb 14, 2017
- Reporting period
- Feb 10, 2017
- Description
- Schedule 13G beneficial ownership